Investment Summary

Ampersand Capital Partners and KKR Invest In Resolian

On November 18, 2021, growth capital firm Ampersand Capital Partners and private equity firm KKR invested in life science company Resolian

Investment Highlights
  • This is Ampersand Capital Partners’ 31st and KKR’s 16th transaction in the Life Science sector.
  • This is Ampersand Capital Partners’ 57th and KKR’s 178th transaction in the United States.
  • This is Ampersand Capital Partners’ 1st and KKR’s 6th transaction in Pennsylvania.

Investment Summary

Date 2021-11-18
Target Resolian
Sector Life Science
Investor(s) Ampersand Capital Partners
KKR
Deal Type Growth Capital

Target

Resolian

Malvern, Pennsylvania, United States
Resolian is a contract research organization (CRO) that specializes in advanced bioanalytical research services for both small and large molecule drugs, as well as drug metabolism studies to support pharmaceutical and biotechnology companies’ drug discovery and development programs. Resolian was founded in 2008 and is headquartered in Malvern, Pennsylvania.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 2

Investor

Ampersand Capital Partners

Wellesley, Massachusetts, United States

Investor Investor Investor Investor Investor


Category Growth Capital Firm
Founded 1988
PE ASSETS 3.0B USD
Size Large
Type Sector Focused
DESCRIPTION

Ampersand Capital Partners is a middle-market private equity group that concentrates on growth equity investment opportunities in the healthcare sector. The Firm looks to invest $10 to $100 million in businesses with $10 to $100 million of revenue. Specific areas of interests within healthcare include lab products, specialty diagnostic equipment, pharmaceutical outsourcing, and specialty pharma. Ampersand generally prefers to be the first and sole institutional investor. Ampersand was formed in 1988 and is based in Wellesley, Massachusetts.


DEAL STATS #
Overall 65 of 86
Sector: Life Science M&A 31 of 43
Type: Growth Capital M&A Deals 18 of 25
State: Pennsylvania M&A 1 of 1
Country: United States M&A 57 of 70
Year: 2021 M&A 9 of 9
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-11-17 Leinco

St. Louis, Missouri, United States

Leinco is a biotechnology company that is engaged in manufacturing of early discovery research products including antibodies, recombinant proteins, ELISA kits, second step reagents, and other life sciences products. Leinco was founded in 1992 and is based in St. Louis, Missouri.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-01-07 AnaBios

San Diego, California, United States

AnaBios is a preclinical contract research organization (CRO) that focuses on translational research with unique capabilities to measure drug activity directly in human tissue. AnaBios is based in San Diego, California.

Buy -
Investor

KKR

New York, New York, United States

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1976
PE ASSETS 267.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION
KKR's office in Menlo Park, California.
KKR's office in Menlo Park, California.

KKR is a global investment firm founded by Jerome Kohlberg, Henry Kravis, and George Roberts. The Firm is separated into several business segments including private markets, public markets, capital markets, and other principal activities. KKR's private equity practice invests in management buyouts, take privates, corporate divestitures, industry consolidations, and partnerships with family-owned companies. KKR will invest in a broad range of industries and companies and will consider businesses throughout North America, Europe, Asia, and Australia/New Zealand. Sectors of interest include chemicals, consumer products, energy and natural resources, financial services, healthcare, industrial, media/communications, retail, and technology. In addition to its traditional principal investment activity business, KKR also invests in infrastructure assets. KKR was formed in 1976 and is based in New York, New York.


DEAL STATS #
Overall 414 of 499
Sector: Life Science M&A 16 of 21
Type: Growth Capital M&A Deals 71 of 81
State: Pennsylvania M&A 6 of 6
Country: United States M&A 178 of 212
Year: 2021 M&A 46 of 52
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-11-15 CyrusOne

Dallas, Texas, United States

CyrusOne is a global REIT specializing in design, construction, and operation of more than 50 high-performance data centers worldwide. TCyrusOne was founded in 2001 and is based in Dallas, Texas.

Buy $15.0B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-11-25 Taylor’s Education

Subang Jaya, Malaysia

Taylor's Education is a private education group with 20,000 students. Taylor’s Education is based in Subang Jaya, Malaysia.

Buy -